CCR3


Also found in: Medical, Wikipedia.
AcronymDefinition
CCR3C-C Chemokine Receptor 3
References in periodicals archive ?
In a study, researchers at the University of North Carolina at Chapel Hill School of Medicine in collaboration with lead investigators at the University of Kentucky have demonstrated that blocking the activity of a specific protein - called CCR3 -- can reduce the abnormal blood vessel growth that leads to macular degeneration.
The discovery and description of a potent inhibitor of the CCR3 receptor -- a protein called Met-Chemokine Beta Seven, or CkB7 -- is contained in the newly published manuscript.
Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.
mRNA production by T cell-associated genes, including CD3D, CCR3, and CD69, and by NK cell-associated genes (KLRD1, KLRK1, and PRF1) shows similar time courses, with highly significant decreases in mRNA production apparent between the preoperative and postoperative time points in both investigated groups (Table 2).
9), (10) The chemokine CCR3 is produced by Th2 lymphocytes and facilitates the migration of eosinophils, which are found in the lesional skin of patients with AD.
the Dana-Farber Cancer Institute and Children's Hospital have demonstrated that a chemokine coreceptor named CCR3 is used by the AIDS virus to enter and infect certain white blood cells, LeukoSite announced today.
Antagonism of the chemokine receptor CCR3 as a potential therapeutic treatment for asthma
66) CCR3 is an eotaxin receptor that is also expressed on mast cells.
1:45: EXPRESSION AND LOCALIZATION OF RANTES AND CORRESPONDING RECEPTORS CCR1, CCR3, AND CCR5 IN PLASMODIUM YOELII INFECTED MOUSE BRAIN, Bismark Y.
Using TOPIGEN's proprietary antisense chemistry designed for the lungs, the drug targets two distinct cellular pathways involved in allergic airway inflammation by inhibiting the recruitment of allergic inflammatory cells, called eosinophils, via the CCR3 receptor and reducing the persistence of allergic inflammatory cells via inhibition of a common beta sub-unit for the receptors of interleukin (IL) 3, 5 and GM-CSF.